[go: up one dir, main page]

ES8404361A1 - Un procedimiento para la preparacion de un derivado de cefalosporina. - Google Patents

Un procedimiento para la preparacion de un derivado de cefalosporina.

Info

Publication number
ES8404361A1
ES8404361A1 ES515548A ES515548A ES8404361A1 ES 8404361 A1 ES8404361 A1 ES 8404361A1 ES 515548 A ES515548 A ES 515548A ES 515548 A ES515548 A ES 515548A ES 8404361 A1 ES8404361 A1 ES 8404361A1
Authority
ES
Spain
Prior art keywords
group
furopyridinium
thieno
relating
cephalosporin derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES515548A
Other languages
English (en)
Other versions
ES515548A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES515548A0 publication Critical patent/ES515548A0/es
Publication of ES8404361A1 publication Critical patent/ES8404361A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN DERIVADO DE CEFALOSPORINA, DE FORMULA GENERAL (I), EN LA QUE R ES HIDROGENO O UN GRUPO ACILO; R ES UN GRUPO BICICLOPIRIDINIO SELECCIONADO ENTRE UN GRUPO TIENOPIRIDINIO Y UN GRUPO FUROPIRIDINIO, Y SUS SALES FARMACEUTICAMENTE ACEPTABLES.CONSISTE EN SOMETER A UNA REACCION DE CONDENSACION UN COMPUESTO DE FORMULA (II), EN LA QUE L ES UN GRUPO SALIENTE; Y R3 ES HIDROGENO O UN GRUPO PROTECTOR DE ESTER, CON UNA TIENO O FUROPIRIDINA.DE APLICACION EN COMPOSICIONES FARMACEUTICAS UTILIZADAS EN EL TRATAMIENTO DE ENFERMEDADES INFECCIOSAS.
ES515548A 1981-09-08 1982-09-07 Un procedimiento para la preparacion de un derivado de cefalosporina. Expired ES8404361A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30035781A 1981-09-08 1981-09-08
US34062882A 1982-01-19 1982-01-19

Publications (2)

Publication Number Publication Date
ES515548A0 ES515548A0 (es) 1984-04-16
ES8404361A1 true ES8404361A1 (es) 1984-04-16

Family

ID=26971737

Family Applications (2)

Application Number Title Priority Date Filing Date
ES515548A Expired ES8404361A1 (es) 1981-09-08 1982-09-07 Un procedimiento para la preparacion de un derivado de cefalosporina.
ES527763A Expired ES8505374A1 (es) 1981-09-08 1983-12-02 Un procedimiento para la preparacion de un derivado de cefalosporina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES527763A Expired ES8505374A1 (es) 1981-09-08 1983-12-02 Un procedimiento para la preparacion de un derivado de cefalosporina

Country Status (17)

Country Link
EP (1) EP0074268A3 (es)
KR (1) KR840001585A (es)
CS (1) CS232735B2 (es)
DD (1) DD209633A5 (es)
DK (1) DK399282A (es)
ES (2) ES8404361A1 (es)
FI (1) FI823088L (es)
GB (1) GB2105719A (es)
GR (1) GR76701B (es)
HU (1) HU187575B (es)
IL (1) IL66726A0 (es)
NZ (1) NZ201833A (es)
PH (1) PH19756A (es)
PL (1) PL238158A1 (es)
PT (1) PT75518B (es)
RO (1) RO84456B (es)
SU (1) SU1169542A3 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0097961B1 (en) * 1982-06-28 1987-11-11 Bristol-Myers Company Cephalosporin derivatives, a process for the manufacture thereof and pharmaceutical compositions containing said derivatives
US4480098A (en) * 1982-11-12 1984-10-30 Eli Lilly And Company Preparation of alkali metal thieno(furo)pyridines
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
EP0137442A3 (de) * 1983-10-08 1986-01-15 Hoechst Aktiengesellschaft Cephalosporinderivate und Verfahren zu ihrer Herstellung
EP0138552A3 (en) * 1983-10-17 1986-03-19 Eli Lilly And Company Improvements on or relating to 3-bicyclicpyridinium-methyl cephalosporins
US4868173A (en) * 1984-11-20 1989-09-19 Ici Pharma Cephalosporin derivatives
EP0187456A1 (en) * 1984-11-29 1986-07-16 Ici Pharma Cephalosporin derivatives
ATE89826T1 (de) * 1985-03-01 1993-06-15 Takeda Chemical Industries Ltd Antibakterielle verbindungen, ihre herstellung und verwendung.
US4703118A (en) * 1985-04-08 1987-10-27 Eli Lilly And Company Synthesis of 3-iodomethyl cephalosporins
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
GB8626245D0 (en) * 1985-11-27 1986-12-03 Ici Pharma Cephalosporin compounds
US4868294A (en) * 1986-07-11 1989-09-19 Bristol-Myers Company Process for preparing cephalosporin intermediates
US4918067A (en) * 1986-07-24 1990-04-17 Beecham Group P.L.C. Heterocyclic substituted penicillin antibiotics
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
US6642238B2 (en) 2000-02-10 2003-11-04 Pharmacia And Upjohn Company Oxazolidinone thioamides with piperazine amide substituents
EP1263742B1 (en) * 2000-02-10 2005-08-24 Pharmacia & Upjohn Company LLC Oxazolidinone thioamides with piperazine amide substituents
US7847093B2 (en) 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime
ATE473986T1 (de) 2003-04-16 2010-07-15 Sandoz Ag Verfahren zur herstellung von cefepim

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
DE2760484C2 (es) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
FR2440738A1 (fr) * 1978-11-13 1980-06-06 Parcor Medicament a base de derives des thieno (2,3-c) et (3,2-c) pyridines
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3207840A1 (de) * 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"

Also Published As

Publication number Publication date
FI823088A7 (fi) 1983-03-09
DK399282A (da) 1983-03-09
EP0074268A2 (en) 1983-03-16
ES515548A0 (es) 1984-04-16
CS650582A2 (en) 1984-06-18
CS232735B2 (en) 1985-02-14
SU1169542A3 (ru) 1985-07-23
GR76701B (es) 1984-08-29
FI823088A0 (fi) 1982-09-07
IL66726A0 (en) 1982-12-31
ES527763A0 (es) 1985-05-16
NZ201833A (en) 1985-09-13
FI823088L (fi) 1983-03-09
PT75518B (en) 1985-11-12
EP0074268A3 (en) 1984-05-23
GB2105719A (en) 1983-03-30
HU187575B (en) 1986-01-28
PL238158A1 (en) 1984-11-19
ES8505374A1 (es) 1985-05-16
KR840001585A (ko) 1984-05-07
PH19756A (en) 1986-06-26
RO84456A (ro) 1984-06-21
PT75518A (en) 1982-10-01
DD209633A5 (de) 1984-05-16
RO84456B (ro) 1984-08-30

Similar Documents

Publication Publication Date Title
ES8404361A1 (es) Un procedimiento para la preparacion de un derivado de cefalosporina.
ES8104190A1 (es) Un procedimiento para la preparacion de derivados de feneta-nolamina
ES8103743A1 (es) Un metodo para la preparacion de derivados de ftalimidina
AR008377A1 (es) Un compuesto derivado de la 3-aroilbencilpiridazinona, una composicion farmaceutica particularmente para el tratamiento de enfermedades inflamatorias o autoinmunes que contiene dicho compuesto
ES2059437T3 (es) Un metodo para preparar una composicion.
CU22305A3 (es) Procedimiento para la preparacion de un derivado de aminoacidos
ES2058527T3 (es) Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen.
GB1069343A (en) Propanolamine derivatives
MX9303441A (es) Procedimiento para la preparacion de acido clavulanico.
DE3870801D1 (de) Gallensaeure-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die sie enthalten.
ES2179996T3 (es) Cefalosporinas de vinil-pirrolidinona con sustituyentes basicos.
ES8603497A1 (es) Procedimiento para preparar derivados de cefalosporina
SE8801514D0 (sv) Farmaceutisk komposition
SE8002322L (sv) Medel for behandling av inflammatoriska tarmsjukdomar
ATE41146T1 (de) Irreversible dopamin-b-hydroxylase-inhibitoren.
FR2395272A1 (fr) Nouveaux medicaments derives de l'acide amidinopenicillanique
ECSP941050A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene
SE7609495L (sv) N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav
ES8601209A1 (es) Procedimiento para preparar derivados de 5h-(1)-benzopirano-(2,3-d)pirimidina
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
ES8800898A1 (es) Un procedimiento para preparar derivados de azetidinona
ES8207505A1 (es) Procedimiento para la preparacion de derivados de fenoxi- aminopropanol substituidos
ES8801205A1 (es) Un procedimiento para la produccion de una isatina y una sal de la misma
ES486580A1 (es) Un procedimiento para preparar compuestos con propiedades broncodilatadoras
MX174093B (es) 1,1-DIOXIDOS DE 3,4-DIHIDRO-2-ALQUIL-3-OXO-N-ARIL-2H[1] BENZOTIENO[3,2-e]-1,2-TIAZINO-4-CARBOXIAMIDA